ANGO News and Press, AngioDynamics Inc. From 04/23/21

Shares of AngioDynamics Inc. (NASDAQ:ANGO) traded at a new 52-week high today of $24.83. So far today approximately 117,000 shares have been exchanged, as compared to an average 30-day volume of 323,000 shares. In the past 52 weeks, shares of AngioDynamics Inc. have traded between a low ...

AngioDynamics had a basically inline fiscal third quarter on strength in AngioVac and Auryon, but the shares have rerated much higher on growing enthusiasm for the company's growth strategy. AngioVac continues to gain shares in relatively small VTE sub-markets, but management's produc...

The following slide deck was published by AngioDynamics, Inc. in conjunction with this event. For further details see: AngioDynamics (ANGO) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow

AngioDynamics (ANGO) has submitted a 510(k) application to the FDA for the AlphaVac System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature. The company anticipates ...

Thrombectomy Device with Off-Circuit Mechanical Aspiration Design for Treatment of Undesirable Intravascular Material in Venous System and Peripheral Vasculature AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for ...

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice Preside...

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: AngioDynamics, Inc. 2021 Q3 - Results - Earnings Call Presentation

AngioDynamics, Inc. (ANGO) Q3 2021 Earnings Conference Call March 30, 2021 8:00 AM ET Company Participants Jim Clemmer - President and Chief Executive Officer Steve Trowbridge - Executive Vice President and Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Ma...

Image source: The Motley Fool. AngioDynamics Inc (NASDAQ: ANGO) Q3 2021 Earnings Call Mar 30, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: AngioDynamics Inc (ANGO) Q3 2021 Earnings Call Transcript

AngioDynamics (ANGO): Q3 Non-GAAP EPS of $0.02 beats by $0.04; GAAP EPS of -$0.09 beats by $0.04.Revenue of $71.2M (+2.0% Y/Y) beats by $2.25M.FY2021 guidance: Net sales of $285M-288M compared to previous projections of net sales between $278M-284M and adjusted earnings per share between $0.0...